Schedule 13G ownership disclosure

ZYNERBA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 98986X109

Event date: 2016-02-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-16-001307
Form type
SC 13G
Filer
Cormorant Global Healthcare Master Fund, LP
CIK
CIK 1618442
Filed
Mar 04, 2016
Reporting period
Feb 23, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub